CBD of Denver, Inc. Announces Operating Business Relaunch Following BioCannabis Agreement and New International Supply Contracts

$CBDDPress releaseOct 26, 2026, 8:30 AM ETRead the release

CBD of Denver announced continued relaunch of Greece-based BioCannabis, its pending share-exchange acquisition target, including new international B2B supply contracts. BioCannabis generated approximately €35,000 in September 2026 revenue and €50,000 in October, up roughly 43% month over month, based on preliminary unaudited management figures.

Key figures

Month over month growth: 43%
Share exchange agreement date: 2026-09-15
Bio cannabis oct 2026 revenue eur: 50000
Bio cannabis sept 2026 revenue eur: 35000

AI analysis

Red flags3 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.